Jodisol Spray

Povidone‑iodine, the active ingredient in Jodisol Spray, is an antiseptic presented as a spray for topical use. It is employed to reduce microbial contamination on skin, wounds and before surgical procedures. GNH USA supplies Jodisol Spray as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Jodisol Spray is a topical antiseptic that acts on a broad range of microorganisms to achieve skin decontamination. - Skin antisepsis: reduces microbial load on intact skin prior to invasive procedures. - Wound cleaning: helps cleanse minor cuts, abrasions and superficial burns by eliminating bacteria. - Pre‑operative skin preparation: prepares the surgical site to lower the risk of postoperative infection.

Adverse reactions may occur following topical application of povidone‑iodine.

Common Side Effects: - Skin irritation: redness, burning or stinging at the application site. - Itching or mild pruritus. - Localized staining of skin or clothing. - Minor allergic contact dermatitis.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with systemic symptoms. - Iodine toxicity manifesting as thyroid dysfunction. - Extensive skin necrosis in cases of prolonged exposure on compromised skin.

Before using Jodisol Spray, consider the following safety measures. - Allergy assessment: avoid use in individuals with known iodine or povidone‑iodine hypersensitivity. - Open wounds: limit application to superficial lesions; do not use on deep or heavily exuding wounds. - Thyroid disorders: monitor patients with hyper‑ or hypothyroidism for potential iodine load effects. - Pediatric use: exercise caution in infants and young children; follow prescriber guidance. - Storage: Store at room temperature below 25°C: keep in original container, protect from moisture and direct sunlight.

Povidone‑iodine may interact with certain systemic therapies and topical agents.

Major Interactions (Avoid): - Thyroid hormone therapy: excess iodine can alter hormone levels, reducing treatment efficacy. - Radioactive iodine (I‑131) therapy: iodine load may diminish radioactive iodine uptake. - Antithyroid medications: iodine exposure may counteract drug action.

Moderate Interactions (Monitor Closely): - Skin sensitizers (e.g., topical corticosteroids): increased risk of dermatitis. - Silver‑containing dressings: potential reduction in antiseptic activity. - Systemic antibiotics: no direct interaction, but monitor infection response when used concurrently.